Mereo and Sentynl Strike Alvelestat Option Deal in Alpha-1 Lung Disease
1 month ago
In Breaking NewsPartnershipsPharma Industry UpdatesResearch UpdatesTop Stories
China’s Biotech Model Is Moving From Asset Export to Integrated Drug Building
2 months ago
In AI & DataBiopharma ManufacturingFeatured AnalysisInnovationPartnershipsTop Stories
The Biohaven Verdict Sends a Warning Through Biotech’s Confidential Deal Rooms
2 months ago
In Featured AnalysisPartnershipsPharma Industry UpdatesTop StoriesVenture Capital
Biotech M&A Roars Back: Why 2026 Is Already the Best Dealmaking Year in Seven Years
2 months ago
In Featured AnalysisPartnershipsTop StoriesVenture Capital
Go to Partnerships